INSIGHTS ON CLINICAL TRIAL DESIGN
-
![cancer-treatment-clinical-trials-GettyImages-1605434136]( "Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape")
Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment LandscapeSee how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.
-
![GettyImages-1316574146-computer-monitoring-office-hands-keyboard]( "Master Protocols: Implementing Effective Treatment Adaptations")
Master Protocols: Implementing Effective Treatment AdaptationsFrom balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.
-
![GettyImages-1309471798 respiratory]( "How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch")
How Expert Medical Information Support Strengthened A Rare Respiratory Therapy LaunchEmbedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.
-
![Real-Time Audit Trail Demo]( "Korio RTSM Platform: Real-Time Audit Trail Demo")
Korio RTSM Platform: Real-Time Audit Trail DemoWatch a real-time walkthrough of Korio’s built-in audit trail. Human-readable, blind-controlled, and fully exportable—see how sponsors get instant access to critical trial data.
-
Mergers And Acquisitions: How Institutional Knowledge Protecting Value5/27/2026
M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.
-
Ocular Endpoint Protection In A Capital-Constrained Market9/3/2025
Ocular Endpoint Protection reframes data capture as a non-negotiable driver of efficiency, and sponsors who embed point-of-need (PON) into their protocols protect both their investment and results.
-
What Drives Attendance And Engagement At Clinical Meetings?5/6/2026
A clear look at what drives attendance and engagement at clinical meetings, and how design decisions shape comprehension, retention, and consistency as programs scale globally over time.
-
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity3/28/2025
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
-
Evidence Of An Industry's Readiness To Collaborate11/13/2024
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1295492925-computer-future-data-research-lab]( "Isotope Labelling")
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
![GettyImages-1819626829 patient recruitment]( "Accelerating Patient Recruitment In Oncology Since 2005")
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.
-
![GettyImages-1135140461-lab-team]( "Accelerate Approval Of Novel Therapies")
Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.
-
![GettyImages-1492337134 doctor notes]( "Clinical Operations And Project Management")
Consider the benefits of an integrated operations and project management approach across all phases and regions.
-
![Medical data iStock-1210343139]( "Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility")
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
